Blackhawk Capital Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,411
Closed -$763K 139
2024
Q3
$763K Buy
6,411
+251
+4% +$33.5K 0.41% 74
2024
Q2
$879K Buy
6,160
+2,329
+61% +$309K 0.53% 67
2024
Q1
$492K Buy
3,831
+124
+3% +$14.8K 0.31% 80
2023
Q4
$383K Buy
+3,707
New +$367K 0.26% 77

Other funds holding NVO

Blackhawk Capital Partners's NVO Position: Q4 2024 in Review

Blackhawk Capital Partners sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 6,411 shares — an estimated $763K sold.

Blackhawk Capital Partners first reported a position in NVO in Q4 2023 and held it in 4 quarters. The position peaked at $879K in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Blackhawk Capital Partners reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Blackhawk Capital Partners sold 6,411 Novo Nordisk shares in Q4 2024, an estimated $763K.
  • Blackhawk Capital Partners first reported a position in Novo Nordisk in Q4 2023 and held it in 4 quarters.
  • Blackhawk Capital Partners's Novo Nordisk position peaked at $879K in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Blackhawk Capital Partners's 13F filing for Q4 2024, filed 4 Feb 2025.